Case number 2020-1328
Eli Lilly and Company v. Apotex, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ELI LILLY AND COMPANY v. APOTEX, INC. [OPINION] [nonprecedential] (0) |
| Jan 27, 2021 | 60 | Mandate issued to the United States District Court for the Southern District of Indiana. Service as of this date by the Clerk of Court. [752124] [MJL] [Entered: 01/27/2021 02:36 PM] (1) |
| Dec 21, 2020 | 59 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [744143] [JAB] [Entered: 12/21/2020 09:47 AM] (1) |
| Dec 21, 2020 | 58 | OPINION filed for the court by Prost, Chief Judge; Bryson, Circuit Judge and Stoll, Circuit Judge. Nonprecedential Opinion. [744142] [JAB] [Entered: 12/21/2020 09:46 AM] (11) |
| Nov 4, 2020 | 57 | Submitted after ORAL ARGUMENT to Panel: Prost, Chief Judge; Bryson, Circuit Judge and Stoll, Circuit Judge.Arguing counsel: William A. Rakoczy for Apotex, Inc. and Adam Lawrence Perlman for Eli Lilly and Company.Oral Argument Audio available here. [733582] [JAB] [Entered: 11/04/2020 12:11 PM] (0) |
| Oct 19, 2020 | 55 | Clerk's letter to Appellant Apotex, Inc. and Appellee Eli Lilly and Company regarding Telephonic Argument Orientation. Service as of this date by the Clerk of Court. [729727] [JAB] [Entered: 10/19/2020 11:03 AM] (0) |
| Oct 16, 2020 | 56 | 6 paper copies of Doc. No. [22] received from Appellant Apotex, Inc.. [732080] [VDW] [Entered: 10/28/2020 02:11 PM] (0) |
| Oct 14, 2020 | 54 | Response to notice of oral argument from the Appellant Apotex, Inc.. Service: 10/14/2020 by email. [728638] [20-1328] [William Rakoczy] [Entered: 10/14/2020 03:00 PM] (1) |
| Oct 14, 2020 | 53 | NOTICE OF NON-COMPLIANCE: The paper copies [45] of Apotex, Inc.'s confidential opening brief are not in compliance with the rules of this court (see attached). Compliant paper copies due 10/21/2020. Service as of this date by the Clerk of Court. [728611] [MJL] [Entered: 10/14/2020 01:30 PM] (1) |
| Sep 22, 2020 | 52 | Response to notice of oral argument from the Appellee Eli Lilly and Company. Service: 09/22/2020 by email. [723748] [20-1328] [Adam Perlman] [Entered: 09/22/2020 04:49 PM] (1) |
| Sep 21, 2020 | 51 | NOTICE OF TELEPHONIC ORAL ARGUMENT. Panel: 2011I. Case scheduled November 4, 2020. Response to Notice of Oral Argument due: 10/15/2020. The Clerk's Office will provide additional instructions to counsel at least one week ahead of argument. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [723160] [JAB] [Entered: 09/21/2020 01:04 PM] (1) |
| Jul 24, 2020 | 50 | 6 paper copies of the Confidential Appendix (Vol. II) [36] received from Appellant Apotex, Inc. and Appellee Eli Lilly and Company. [710860] [CJF] [Entered: 07/29/2020 09:02 AM] (0) |
| Jul 22, 2020 | 49 | NOTICE OF NON-COMPLIANCE: The submission of Appellant Apotex, Inc. and Appellee Eli Lilly and Company, paper copies of confidential appendix [48], is not in compliance with the rules of this court (see attached). Compliant document due on 07/29/2020. Service as of this date by the Clerk of Court. [709271] [CJF] [Entered: 07/22/2020 01:52 PM] (1) |
| Jul 14, 2020 | 48 | 6 paper copies of the Confidential Appendix (Vol. I - IV) [36] received from Appellant Apotex, Inc. and Appellee Eli Lilly and Company. This document is non-compliant. See Doc No. [709213][49] [CJF] [Entered: 07/22/2020 12:15 PM] (0) |
| Jul 14, 2020 | 47 | 6 paper copies of the Confidential Reply Brief [34] received from Appellant Apotex, Inc. [709212] [CJF] [Entered: 07/22/2020 12:13 PM] (0) |
| Jul 14, 2020 | 46 | 6 paper copies of the Confidential Opening Response Brief [26] received from Appellee Eli Lilly and Company. [709194] [CJF] [Entered: 07/22/2020 11:33 AM] (0) |
| Jul 14, 2020 | 45 | 6 paper copies of the Confidential Opening Brief [22] received from Appellant Apotex, Inc. [709171]. These copies are non-compliant. See Doc. No. [53]. [CJF] [Entered: 07/22/2020 10:49 AM] (0) |
| Jul 14, 2020 | 44 | Notice from Appellant Apotex, Inc. regarding conflicts with oral argument. Service: 07/14/2020 by email. [707526] [20-1328] [Joseph Jaros] [Entered: 07/14/2020 05:35 PM] (2) |
| Jul 8, 2020 | 43 | MODIFIED ENTRY: Notice from Appellee Eli Lilly and Company regarding conflicts with oral argument. Service: 07/08/2020 by email. [706198]--[Edited 07/09/2020 by JAL - Reason: to correct filing event] [Adam Perlman] [Entered: 07/08/2020 04:40 PM] (2) |
| Jul 8, 2020 | 42 | Outstanding paper copies of all briefs and appendices must be submitted no later than 07/16/2020. Refer to Admin. Order No. 20-01. [706140] [MJL] [Entered: 07/08/2020 02:28 PM] (0) |
| Jul 8, 2020 | 41 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [706138] [MJL] [Entered: 07/08/2020 02:24 PM] (1) |
| Jun 22, 2020 | 40 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellee Eli Lilly and Company. Service: 06/22/2020 by email. [702915] [20-1328] [David Krinsky] [Entered: 06/22/2020 07:49 PM] (3) |
| Jun 22, 2020 | 39 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Apotex, Inc.. Service: 06/22/2020 by email. [702909] [20-1328] [William Rakoczy] [Entered: 06/22/2020 07:20 PM] (3) |
| Jun 22, 2020 | 38 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellant Apotex, Inc. and Appellee Eli Lilly and Company. Service: 06/22/2020 by email. [702904] [20-1328] [William Rakoczy] [Entered: 06/22/2020 07:13 PM] (3) |
| Jun 22, 2020 | 37 | MODIFIED ENTRY: APPENDIX FILED for Apotex, Inc. and Eli Lilly and Company. Number of Pages: 1449. Service: 06/22/2020 by email. [702901]--[Edited 07/08/2020 by MJL - compliance review complete] [William Rakoczy] [Entered: 06/22/2020 07:09 PM] (1449) |
| Jun 22, 2020 | 36 | MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED for Apotex, Inc. and Eli Lilly and Company. Number of Pages: 1449. Service: 06/22/2020 by email. [702895]--[Edited 07/08/2020 by MJL - compliance review complete] [William Rakoczy] [Entered: 06/22/2020 06:25 PM] (0) |
| Jun 15, 2020 | 35 | MODIFIED ENTRY: REPLY BRIEF FILED for Appellant Apotex, Inc. Number of Pages: 32. Service: 06/15/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [701281] --[Edited 06/30/2020 by LMN - compliance review complete] [William Rakoczy] [Entered: 06/15/2020 05:21 PM] (41) |
| Jun 15, 2020 | 34 | MODIFIED ENTRY: CONFIDENTIAL REPLY BRIEF FILED for Appellant Apotex, Inc. Number of Pages: 32. Service: 06/15/2020 by email. [701280]--[Edited 06/30/2020 by LMN - compliance review complete] [William Rakoczy] [Entered: 06/15/2020 05:18 PM] (0) |
| Jun 1, 2020 | 33 | **TEXT ONLY** ORDER granting Apotex, Inc.'s motion [31] to extend the time to file the reply brief by 7 days, until 06/15/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [698316] [MJL] [Entered: 06/01/2020 03:15 PM] (0) |
| May 29, 2020 | 30 | Entry of appearance for Xiaomei Cai as of counsel for Appellant Apotex, Inc.. Service: 05/29/2020 by email. [697948] [20-1328] [William Rakoczy] [Entered: 05/29/2020 03:42 PM] (2) |
| May 29, 2020 | 31 | MOTION of Appellant Apotex, Inc. to extend the time to 06/15/2020 to file the Appellant's Reply Brief. [Consent: unopposed]. Service: 05/29/2020 by email. [697953] [20-1328] [William Rakoczy] [Entered: 05/29/2020 03:48 PM] (8) |
| May 29, 2020 | 32 | Amended Certificate of Interest for Appellant Apotex, Inc.. Service: 05/29/2020 by email. [697958] [20-1328] [William Rakoczy] [Entered: 05/29/2020 03:58 PM] (3) |
| May 26, 2020 | 29 | Corrected Certificate of Service filed by Appellee Eli Lilly and Company to Doc No. [26]. Service: 05/26/2020 by email. [697027] [20-1328] [Adam Perlman] [Entered: 05/26/2020 10:32 PM] (1) |
| May 26, 2020 | 28 | Certificate of Compliance with the Confidentialtiy Requirement of Fed. Cir. R. 28(d) (Briefs) for Appellee Eli Lilly and Company. Service: 05/26/2020 by email. [697026] [20-1328] [Adam Perlman] [Entered: 05/26/2020 10:29 PM] (1) |
| May 18, 2020 | 27 | MODIFIED ENTRY: BRIEF FILED for Eli Lilly and Company. Number of Pages: 67. Service: 05/18/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of the confidential version of this brief. See Fed. Cir. R. 31. [695499]--[Edited 05/27/2020 by MJL - compliance review complete] [Adam Perlman] [Entered: 05/18/2020 10:37 PM] (79) |
| May 18, 2020 | 26 | MODIFIED ENTRY: CONFIDENTIAL BRIEF FILED for Eli Lilly and Company. Number of Pages: 67. Service: 05/18/2020 by email. [695498]--[Edited 05/27/2020 by MJL - compliance review complete] [Adam Perlman] [Entered: 05/18/2020 10:36 PM] (0) |
| Apr 6, 2020 | 25 | **TEXT ONLY** ORDER granting motion to extend time to file brief [24] filed by Appellee Eli Lilly and Company. The response brief is due 05/18/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [684224] [LMN] [Entered: 04/06/2020 09:13 AM] (0) |
| Apr 3, 2020 | 24 | MOTION of Appellee Eli Lilly and Company to extend the time to 05/18/2020 to file the Eli Lilly and Company's Responsive Brief. [Consent: unopposed]. Service: 04/03/2020 by email. [684138] [20-1328] [David Krinsky] [Entered: 04/03/2020 04:52 PM] (10) |
| Mar 17, 2020 | 23 | MODIFIED ENTRY: BRIEF FILED for Apotex, Inc. Number of Pages: 69. Service: 03/17/2020 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of the confidential version. See Fed. Cir. R. 31. [679651]--[Edited 03/18/2020 by MJL - compliance review complete] [William Rakoczy] [Entered: 03/17/2020 08:00 PM] (141) |
| Mar 17, 2020 | 22 | MODIFIED ENTRY: CONFIDENTIAL BRIEF FILED for Apotex, Inc. Number of Pages: 69. Service: 03/17/2020 by email. [679650]--[Edited 03/18/2020 by MJL - compliance review complete] [William Rakoczy] [Entered: 03/17/2020 07:57 PM] (0) |
| Mar 17, 2020 | 21 | Amended Certificate of Interest for Appellant Apotex, Inc.. Service: 03/17/2020 by email. [679649] [20-1328] [William Rakoczy] [Entered: 03/17/2020 07:54 PM] (2) |
| Feb 27, 2020 | 20 | **TEXT ONLY** ORDER granting motion to extend time to file brief [18] filed by Appellant Apotex, Inc. The opening brief is due 03/17/2020. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [674818] [JAL] [Entered: 02/27/2020 01:23 PM] (0) |
| Feb 27, 2020 | 19 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a) and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [674816] [JAL] [Entered: 02/27/2020 01:22 PM] (0) |
| Feb 25, 2020 | 18 | MOTION of Appellant Apotex, Inc. to extend the time to 03/17/2020 to file the Appellant Opening Brief. [Consent: unopposed]. Service: 02/25/2020 by email. [674023] [20-1328] [William Rakoczy] [Entered: 02/25/2020 01:11 PM] (8) |
| Jan 30, 2020 | 17 | Entry of appearance for Michael Xun Liu as of counsel for Appellee Eli Lilly and Company. Service: 01/30/2020 by email. [667310] [20-1328] [Xun Liu] [Entered: 01/30/2020 01:27 PM] (2) |
| Jan 24, 2020 | 16 | Amended Entry of appearance for Adam L. Perlman as principal counsel for Appellee Eli Lilly and Company. Service: 01/24/2020 by email. [665928] [20-1328] [Adam Perlman] [Entered: 01/24/2020 02:42 PM] (3) |
| Jan 16, 2020 | 15 | Docketing Statement for the Appellant Apotex, Inc.. Service: 01/16/2020 by email. [663834] [20-1328] [William Rakoczy] [Entered: 01/16/2020 02:00 PM] (4) |
| Jan 16, 2020 | 14 | Certificate of Interest for Appellant Apotex, Inc.. Service: 01/16/2020 by email. [663830] [20-1328] [William Rakoczy] [Entered: 01/16/2020 01:58 PM] (3) |
| Jan 16, 2020 | 13 | Entry of appearance for Rachel Pernic Waldron as of counsel for Appellant Apotex, Inc.. Service: 01/16/2020 by email. [663827] [20-1328] [William Rakoczy] [Entered: 01/16/2020 01:54 PM] (2) |
| Jan 16, 2020 | 12 | Entry of appearance for Joseph T. Jaros as of counsel for Appellant Apotex, Inc.. Service: 01/16/2020 by email. [663826] [20-1328] [William Rakoczy] [Entered: 01/16/2020 01:52 PM] (2) |
| Jan 16, 2020 | 11 | Entry of appearance for Cynthia H. Sun as of counsel for Appellant Apotex, Inc.. Service: 01/16/2020 by email. [663825] [20-1328] [William Rakoczy] [Entered: 01/16/2020 01:50 PM] (2) |
| Jan 16, 2020 | 10 | Entry of appearance for William A. Rakoczy as principal counsel for Appellant Apotex, Inc.. Service: 01/16/2020 by email. [663822] [20-1328] [William Rakoczy] [Entered: 01/16/2020 01:48 PM] (2) |
| Jan 13, 2020 | 9 | Entry of appearance for Charles L. McCloud as of counsel for Appellee Eli Lilly and Company. Service: 01/13/2020 by email. [662580] [20-1328] [Charles McCloud] [Entered: 01/13/2020 03:02 PM] (2) |
| Jan 13, 2020 | 8 | Entry of appearance for Andrew P. Lemens as of counsel for Appellee Eli Lilly and Company. Service: 01/13/2020 by email. [662578] [20-1328] [Andrew Lemens] [Entered: 01/13/2020 02:59 PM] (2) |
| Jan 13, 2020 | 7 | Entry of appearance for James P. Leeds as of counsel for Appellee Eli Lilly and Company. Service: 01/13/2020 by email. [662576] [20-1328] [James Leeds] [Entered: 01/13/2020 02:55 PM] (2) |
| Jan 13, 2020 | 6 | Entry of appearance for David M. Krinsky as of counsel for Appellee Eli Lilly and Company. Service: 01/13/2020 by email. [662575] [20-1328] [David Krinsky] [Entered: 01/13/2020 02:51 PM] (2) |
| Jan 13, 2020 | 5 | Entry of appearance for Dov P. Grossman as of counsel for Appellee Eli Lilly and Company. Service: 01/13/2020 by email. [662574] [20-1328] [Dov Grossman] [Entered: 01/13/2020 02:48 PM] (2) |
| Jan 13, 2020 | 4 | Docketing Statement for the Appellee Eli Lilly and Company. Service: 01/13/2020 by email. [662572] [20-1328] [Adam Perlman] [Entered: 01/13/2020 02:45 PM] (3) |
| Jan 13, 2020 | 3 | Certificate of Interest for Appellee Eli Lilly and Company. Service: 01/13/2020 by email. [662570] [20-1328] [Adam Perlman] [Entered: 01/13/2020 02:44 PM] (3) |
| Jan 13, 2020 | 2 | Entry of appearance for Adam L. Perlman as principal counsel for Appellee Eli Lilly and Company. Service: 01/13/2020 by email. [662569] [20-1328] [Adam Perlman] [Entered: 01/13/2020 02:42 PM] (2) |
| Jan 7, 2020 | 1 | Appeal docketed. Received: 12/31/2019. [661174]Entry of Appearance due 01/21/2020. Certificate of Interest is due on 01/21/2020. Docketing Statement due 01/21/2020. Appellant's brief is due 03/09/2020. [TAM] [Entered: 01/07/2020 09:51 AM] (75) |
